Electronic Nose Technology for Early Detection of Ovarian Cancer
Electronic nose technology may detect early signs of ovarian cancer through blood analysis. Promising advancements in cancer diagnosis. π©Ίπ¬
April 20, 2026
Follow us
latest articles
Discover the newest research about AI innovations in 𧬠Genetics.
AICellType: a large language model-based platform for accurate cell type annotation.
AICellType: A breakthrough in cell type annotation with 76% accuracy using LLMs! π§¬π Explore its capabilities!
April 20, 2026
Multi-omics applications in health and diseases.
Multi-omics integration enhances precision medicine, addressing disease complexity with AI-driven analysis. Key for future healthcare advancements! ππ¬
April 16, 2026
AI-Driven Protein Design Enhances Development of Intracellular Antibodies
AI-driven protein design improves the creation of stable intracellular antibodies, aiding diagnostics and biomedical research. π§¬π¬
April 10, 2026
Radiomics and artificial intelligence-based prediction of tumor response in digestive system neoplasm: a systematic review and meta-analysis.
Radiomics & AI enhance tumor response prediction in GI neoplasms. Key findings: ORs range from 8.12 to 11.62. ππ
March 26, 2026
Classification of Osteoporosis and Detection of Compression Fractures by Implementing Real-Time Object Detection System Upon Medical Radiographs.
AI in Osteoporosis Detection: YOLOv4 achieves 78.1% accuracy for osteoporosis classification and 68.3% for fractures. ππ¦΄
March 21, 2026
BioPathNet: A New AI Tool for Analyzing Biomedical Data Networks
BioPathNet is an AI tool for analyzing biomedical data networks, aiding in gene functions and disease mechanisms. π§¬π
March 19, 2026
Digital transformation of Jiangxiangxing Baijiu production: integrating flavor compound analysis, machine learning recognition, and genetic algorithm blending of multi-rounds.
Digital transformation in Jiangxiangxing Baijiu production: flavor analysis, machine learning, and genetic algorithms enhance blending precision. πΆπ¬
March 9, 2026
Clinical development of molecular residual disease (MRD) and multi-cancer early detection (MCED) using liquid biopsy multiomics with artificial intelligence (AI).
Revolutionizing cancer detection: AI-driven multi-omics enhances sensitivity for MRD and MCED assays. ππ¬
March 7, 2026
[Reconstruction of superficial organs: a leap from structural restoration to functional rehabilitation].
Revolutionary advances in superficial organ reconstruction: merging surgical techniques with AI and 3D printing for enhanced functionality. π§¬π¬
February 2, 2026